Lowest Price Guaranteed
Pages
123
Last Updated
August 2025
View Count
11205
The global flow cytometry market size is valued at USD 5.1 billion in 2024 and is poised to reach USD 10.75 billion in 2032, representing a CAGR of 8.25% during the forecast period.
Flow cytometry is a technique used in biology and medicine to measure various physical and chemical characteristics of cells or particles suspended in a fluid as they pass through a laser beam. The method helps in providing quantitative data about the cells classifying cell types and identifying the residual level of diseases. It also provides the cell's granularity, shape, and presence or absence of specific cell surface markers or intracellular molecules. Primarily, two types of techniques are present in the market such as cell-based and bead-based flow cytometry.
The ability of the technique to analyze large numbers of cells with high sensitivity and specificity makes it a popular technology and is widely utilized in academic research, clinical diagnostics, drug discovery, immunology, hematology, and many other fields. The demand for flow cytometry technology has been rising over the past few years majorly due to the continuous technological advancements in flow cytometry instruments.
With the help of advanced technology, companies are developing high-parameter analyzers, imaging flow cytometers, and spectral analyzers that are expanding the capabilities and application of the technology. Such advancements strengthen data resolution, sensitivity, and multiplexing capabilities,
Additionally, increasing research and development activities, expansion of biopharmaceutical and biotechnology industries, and rising prevalence of chronic diseases and infectious diseases such as cancer, and HIV/ AIDS around the world are attributed to drive the flow cytometry market growth. Besides, the rising initiative in the field of immunology and immuno-oncology research and expanding applications in clinical diagnostics are further anticipated to accelerate the market growth.
The adoption of recombinant DNA technology for antibody production and the evolving pipeline for stem cell research is expected to provide substantial growth opportunities for key market players in the flow cytometry sector. However, the high cost of instruments and consumables can hinder the growth of the market.
The market research report presents an in-depth analysis of the various companies that are engaged in the global market of flow cytometry, across different segments, as defined in the table below:
| Key Report Attribute | Details | |
| Historical Trend | 2018-2023 | |
| Base Year | 2023 | |
| Forecast Period | 2024–2032 | |
| Market Size 2024 | USD 5.1 Billion | |
| CAGR | ~8.25% | |
| Type of Product |
|
|
| Type of Technology |
|
|
| Type of Application |
|
|
| Type of End-User |
|
|
| Type of Distribution Channel |
|
|
| Key Geographical Regions |
|
|
| Key Companies Profiled |
|
|
| PowerPoint Presentation (Complimentary) |
Available | |
| Customization Scope | 15% Free Customization | |
| Excel Data Packs (Complimentary) |
|
|
One of the key objectives of this market report was to estimate the current market size, opportunity, and future growth potential of the flow cytometry market size, over the forecast period. Based on multiple parameters, likely adoption trends, and through primary validations, we have provided an informed estimate of the market evolution during the forecast period 2024-2032. The market report also features the likely distribution of the current and forecasted opportunity across various segments, such as type of product (reagents and consumables, flow cytometry instruments, accessories, services, and software), type of technology (cell-based flow cytometry and bead-based flow-based cytometry), type of application, (research applications, clinical applications, and industrial applications), type of end-user (pharmaceuticals & biotechnology companies, academic & research institutes, hospitals, clinical testing laboratories, blood bank, and others), type of distribution channel (retail sales and direct tenders), and key geographical regions (North America, Europe and Asia Pacific, Latin America, Middle East, North Africa and rest of the world).
In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s growth.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
Based on the type of product, the market for flow cytometry is split into reagents and consumables, flow cytometry instruments, accessories, flow cytometry services, and software. Reagents and consumables are expected to dominate the segment with more than 54% of the total flow cytometry market share in 2024. The advantages of reagents and consumables in a wide range of clinical applications such as sample preparation, staining, and analysis in flow cytometry are likely to drive segment growth. Besides, the rising launch of specific application reagents with high quality is further anticipated to support the growth of the market over the forecast period 2024-2032.
Based on the type of technology, the global flow cytometry market is categorized into cell-based flow cytometry and bead-based flow cytometry. As per market research, cell-based flow cytometry holds 66% of the market shares and is most likely to dominate the type of technology segment throughout this projection timeframe. The mounting demand for early diagnosis particularly, of chronic diseases such as cancer and HIV, and the boost in the adoption of cell-based systems due to the growing awareness of the advantages associated with cell-based assay are the significant factors contributing to the segment's growth. In addition, its cell sorting capabilities, automation, and versatility aid in inflating its demand in research, diagnostics, and therapeutic development which will likely enhance the growth of the flow cytometry industry during this forecast period.
Based on the type of application, the global flow cytometry market is bifurcated into research & clinical applications and industrial applications. In research & clinical applications, immunophenotyping, cell cycle analysis, cell sorting, and others are significant applications. According to a market review, clinical application is likely to obtain the largest market share (45%) of the market. The highest growth share can be attributed by the fact that flow cytometer is essential for studying immune cell populations, stem cells research, identifying disease-specific biomarkers, and monitoring immune responses. Furthermore, the rising prevalence of infectious diseases demand advance flow cytometer for diagnosing and point-of-care testing. Consequently, these factors are attributed to driving the market segment’s growth over the forecast period.
On the basis of the type of end-user, the global market for flow cytometry is divided into pharmaceuticals & biotechnology companies, academic research institutes, hospitals, clinical testing laboratories, blood banks, and others. As per our projection, academic & research institutes hold 31% share of the flow cytometry market. This is mainly owing to the proliferating use of flow cytometry in research programs in various disciplines including immunology, cancer biology, molecular biology, and infectious diseases monitoring. Further, augmenting grants and funding in public-private organizations for basic research, technology development, and transitional studies as well as collaboration among researchers from different departments, disciplines, and institutions are contributing to driving the growth of the segment.
Based on the type of distribution, the global flow cytometry market is segregated into retail sales and direct tenders. According to this projection, the retail sales are anticipated to capture the largest market share, holding 55% of overall revenue share. They are expected to be a leading segment as direct tenders or sales provide manufacturers the flexibility, agility, and customer-centric approach which is required to effectively serve the diverse needs of the global clients.’
This segment highlights the distribution of the flow cytometry industry across various geographies, such as North America, Europe, Asia-Pacific, Latin America, Middle East, and North Africa. As per market research, North America holds 40% of the flow cytometry market share in 2024. The factors behind the growth of the market can be attributed to the region’s robust ecosystem for research and development activities for technological advancements and innovative flow cytometry technology. Moreover, particularly, the U.S. and Canada play a vital role in stimulating market growth with the rise in the incidence of chronic diseases such as HIV/AIDS, and cancer, and the presence of key players in the region. Also, the strong biopharmaceutical industry, stringent regulatory environment, and government support through funds and grants for research programs for the development of treatment options for targeted diseases foster the growth of the market in the region.
Additionally, Asia Pacific is emerging as the fastest-growing region and is anticipated to sprout out with exceptional CAGR during this forecast period with the rapidly expanding biotechnology and pharmaceutical industry in the region. In addition to this, soaring healthcare infrastructure in developing nations particularly, in China and India boosts the demand for advanced medical technology including flow cytometry. Escalating government funding and initiatives, and the prevalence of chronic diseases within the largest population will reinforce flow cytometry market growth in the Asia Pacific.
The “Flow Cytometry Market: Industry Trends and Global Forecasts, till 2032” market report features an extensive study of the current market landscape, market size, market forecast and future opportunities for the companies involved in the flow cytometry industry. The market report highlights the efforts of several manufacturers of products and services in this rapidly emerging segment of the pharmaceutical industry. Key takeaways of the market report are briefly discussed below.
In the flow cytometry market, the presence of numerous companies including prominent manufacturing leaders, and key stakeholders participating in their production, development, distribution, and flow cytometry instrument services, reagents, and software solutions, are boosting the competitive landscape and changing market dynamics. Some of the key players in the market are, Agilent Technologies, BD, Bio-Rad Laboratories, Inc., Beckman Coulter, BIOMÉRIEUX, Merck KGaA, Miltenyi Biotec, BioLegend, and Thermo Fisher Scientific which influence the growth of the market and raised the market competition.
Notable companies focus on high investment in R&D to generate innovative products and solutions equipped with advanced technology to cater to changing customer’s requirements. Also, these notable companies emphasize technological advancements, new product launches, a customer-centric approach, collaboration, partnership, mergers, and acquisitions to expand market reach geographically. For instance, In January 2024, Thermo Fisher Scientific collaborated with The Centre for Molecular and Cellular Platforms (C-CAMP) to establish a Centre of Excellence in Bengaluru. The state-of-the-art facility aims to drive innovation and accelerate breakthroughs in India's biotech sector, equipped with advanced workflow solutions.
Recently, the market has been evolving rapidly with a growing focus on the development of next-generation flow cytometry solutions to control the limitations of traditional technologies suited for genetic imaging methodologies. With the innovation of these next-generation cytometers, the instrument can stain cells with various colors at once which enhances the number of leukemia-related immunophenotypes which can be followed. Consequently, the availability of these advanced technologies is anticipated to augment the flow cytometry market growth over this forecast period. For instance, in May 2023, FlowMetric, a subsidiary of KCA Bio, declared a collaboration with Cytek Bioscience, a healthcare company, to implement next-generation flow cytometry technology.
In many pharmaceutical companies, research organizations and academic institutes, there is a requirement of more than one flow cytometer for disease diagnosing and clinical studies on therapeutic drugs. The high initial cost associated with flow cytometer and its installation may create a barrier specifical for small research institutes in adopting these latest technologies on a large scale. Additionally, flow cytometers require maintenance on regular intervals of time which further enhances expenditure of these technologies. Moreover, the complexity associated with operation of flow cytometer, bulky size and requirement of skilled personnel has further limited the adoption of these instruments on a large scale.
With the growing demand for flow cytometry instruments in a diverse range of applications, the market for flow cytometry is evolving rapidly. Single-cell analysis is one of the latest trends in the market. This trend of single-cell analysis enables researchers to study individual cells within heterogeneous populations. Also, development in microfluidics, imaging, and data analysis facilitate the feature of cellular interactions and intracellular signaling pathways at the single-cell level. Furthermore, imaging flow cytometry integrated with artificial intelligence and machine learning is also gaining traction in the market. It uses high throughput capabilities of flow cytometry with the imaging resolution of microscopy and allows visualization and analysis of cellular morphology, spatial organization, and subcellular structures. This imaging flow cytometry offers extra context to flow cytometry data and improves the understanding of cellular functions and phenotypes. AI Integrated flow cytometry technology improves the accuracy, efficiency, and reproducibility of flow cytometry data analysis which provides deeper insights.
Examples of key companies engaged in the flow cytometry industry (which have also been profiled in this market report; the complete list of companies is available in the full report) include Sysmex Corporation, Agilent Technologies, Inc., BD, Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Sony Biotechnology Inc., Apogee Flow Systems, Cytek Biosciences, BIOMÉRIEUX, Merck KGaA, Miltenyi Biotec, Takara Bio Inc., Thermo Fisher Scientific, Q2 Solutions, CellKraft Biotech Pvt. Ltd., Sartorius AG, NeoGenomics Laboratories, Cell Signaling Technology, Inc., CytoBuoy, ORFLO Technologies, IKEDA SCIENTIFIC Co., Ltd., BioLegend, Beckman Coulter, Cytonome/ST, LLC, Stratedigm, Inc, NanoCellect Biomedical, BennuBio Inc., Nexcelom Bioscience LLC, On-chip Biotechnologies Co., Ltd. Corporation, and Enzo Biochem Inc, among others.
Several ongoing innovations and developments are projected to boost market potential. These developments, even if they took place post the release of our market report, substantiate the overall trends that have been outlined in our flow cytometry market analysis.